Regulatory Challenges
Ann and her team faced significant regulatory hurdles while scaling 23andMe, employing creative workarounds to navigate legal restrictions. When the FDA issued a cease and desist letter, Ann initially underestimated its seriousness, but soon realized the gravity of the situation. Her instinct was to advocate for consumer rights, sparking a pivotal shift in her approach as she grappled with the complexities of regulation and innovation.In this clip
From this podcast
Masters of Scale
23andMe's Anne Wojcicki: Embrace the gatekeepers
Related Questions